Francis Knuettel II - 01 Nov 2024 Form 3 Insider Report for Innovation1 Biotech Inc.

Role
Chairman and Interim CEO, Director
Signature
/s/ Francis Knuettel II
Issuer symbol
N/A
Transactions as of
01 Nov 2024
Net transactions value
$0
Form type
3
Filing time
04 Feb 2025, 06:54:33 UTC
Previous filing
16 Sep 2024
Next filing
15 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVBT Series C Senior Convertible Preferred Stock 01 Nov 2024 Common Stock 1,023,511,950 By Camden Capital LLC F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person holds 600,000 shares of Series C Senior Convertible Preferred Stock. Each share of Series C Senior Convertible Preferred Stock is convertible into shares of the Issuer's common stock at any time by dividing the Stated Value of $0.001 by the Conversion Price of $0.000000586216897634410.
F2 Represents shares of Series C Senior Convertible Preferred Stock held by Camden Capital LLC, an entity which the Reporting Person holds voting and investment control.
F3 Conversion Price is $0.000000586216897634410.